ASEP — Asep Medical Holdings Cashflow Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual cashflow statement for Asep Medical Holdings, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -2.34 | -5.76 | -9.43 | -13.7 |
| Depreciation | ||||
| Deferred Taxes | ||||
| Non-Cash Items | 1.3 | 1.37 | 3.77 | 10.1 |
| Unusual Items | ||||
| Equity in Net Earnings/Losses | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -0.32 | -0.42 | 1.65 | 1.97 |
| Change in Accounts Receivable | ||||
| Change in Prepaid Expenses | ||||
| Change in Payable / Accrued Expenses | ||||
| Change in Other Liabilities | ||||
| Cash from Operating Activities | -1.19 | -3.61 | -2.71 | -0.337 |
| Capital Expenditures | -0.116 | 0 | -0.001 | -0 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | 0.262 | 0.125 | -0.003 | — |
| Sale of Business | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | 0.146 | 0.125 | -0.004 | -0 |
| Financing Cash Flow Items | -0.061 | 0 | -0.016 | 0.292 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 6.34 | 0.33 | 0.651 | 0.292 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 5.29 | -3.16 | -2.07 | -0.046 |